CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scholz, G. M.
Right arrow Articles by Dunn, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scholz, G. M.
Right arrow Articles by Dunn, A. R.
Cell Growth & Differentiation Vol. 12, 409-417, August 2001
© 2001 American Association for Cancer Research

The Molecular Chaperone Hsp90 Is Required for Signal Transduction by Wild-Type Hck and Maintenance of Its Constitutively Active Counterpart1

Glen M. Scholz2, Steven D. Hartson, Kellie Cartledge, Lenora Volk, Robert L. Matts and Ashley R. Dunn

Molecular Biology Laboratory, Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Victoria 3050, Australia [G. M. S., K. C., A. R. D.], and Department of Biochemistry and Molecular Biology, Oklahoma State University, Stillwater, Oklahoma 74078 [S. D. H., L. V., R. L. M.]

We have investigated the relationship between the molecular chaperone heat shock protein-90 (Hsp90) and the signal transducing capacity of the Src-family kinase Hck. Inhibition of Hsp90 with geldanamycin suppressed the ability of bacterial lipopolysaccharide to enhance the cell adhesion properties of macrophages, a phenomenon most likely explained by the reduced expression and activity of Hck in macrophages lacking Hsp90 function. The contribution of Hsp90 to signal transduction by Hck was biochemically dissected further by examining its role in the de novo folding and maintenance of wild-type Hck and its constitutively active counterpart, Hck499F. The folding of nascent wild-type Hck and Hck499F into catalytically active conformations, and their accumulation in cells was found to be dependent on Hsp90 function. Notably, mature Hck499F had a greater requirement for on-going support from Hsp90 than did mature wild-type Hck. This particular finding might have important implications for our understanding of the evolution of oncogenic protein kinases.




This article has been cited by other articles:


Home page
BloodHome page
F. Lupo, E. Tibaldi, A. Matte, A. K. Sharma, A. M. Brunati, S. L. Alper, C. Zancanaro, D. Benati, A. Siciliano, M. Bertoldi, et al.
A new molecular link between defective autophagy and erythroid abnormalities in chorea-acanthocytosis
Blood, December 22, 2016; 128(25): 2976 - 2987.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. J. Smolinska, T. H. Page, A. M. Urbaniak, B. E. Mutch, and N. J. Horwood
Hck Tyrosine Kinase Regulates TLR4-Induced TNF and IL-6 Production via AP-1
J. Immunol., December 1, 2011; 187(11): 6043 - 6051.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Trentin, M. Frasson, A. Donella-Deana, F. Frezzato, M. A. Pagano, E. Tibaldi, C. Gattazzo, R. Zambello, G. Semenzato, and A. M. Brunati
Geldanamycin-induced Lyn dissociation from aberrant Hsp90-stabilized cytosolic complex is an early event in apoptotic mechanisms in B-chronic lymphocytic leukemia
Blood, December 1, 2008; 112(12): 4665 - 4674.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
L. M. Karnitz and S. J. Felts
Cdc37 Regulation of the Kinome: When to Hold 'Em and When to Fold 'Em
Sci. Signal., May 8, 2007; 2007(385): pe22 - pe22.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
S. J. H. Arlander, S. J. Felts, J. M. Wagner, B. Stensgard, D. O. Toft, and L. M. Karnitz
Chaperoning Checkpoint Kinase 1 (Chk1), an Hsp90 Client, with Purified Chaperones
J. Biol. Chem., February 3, 2006; 281(5): 2989 - 2998.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
D. De Nardo, P. Masendycz, S. Ho, M. Cross, A. J. Fleetwood, E. C. Reynolds, J. A. Hamilton, and G. M. Scholz
A Central Role for the Hsp90{middle dot}Cdc37 Molecular Chaperone Module in Interleukin-1 Receptor-associated-kinase-dependent Signaling by Toll-like Receptors
J. Biol. Chem., March 18, 2005; 280(11): 9813 - 9822.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
S. J. Lavictoire, D. A. E. Parolin, A. C. Klimowicz, J. F. Kelly, and I. A. J. Lorimer
Interaction of Hsp90 with the Nascent Form of the Mutant Epidermal Growth Factor Receptor EGFRvIII
J. Biol. Chem., February 14, 2003; 278(7): 5292 - 5299.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2001 by the American Association of Cancer Research.